146 related articles for article (PubMed ID: 29055875)
1. Stability behaviour of antiretroviral drugs and their combinations. 8: Characterization and in-silico toxicity prediction of degradation products of efavirenz.
Kurmi M; Sahu A; Singh DK; Singh IP; Singh S
J Pharm Biomed Anal; 2018 Jan; 148():170-181. PubMed ID: 29055875
[TBL] [Abstract][Full Text] [Related]
2. Stability behaviour of antiretroviral drugs and their combinations. 10: LC-HRMS, LC-MS
Singh DK; Sahu A; Wani AA; Bharatam PV; Kotimoole CN; Batkulwar KB; Deshpande AY; Giri S; Singh S
Eur J Pharm Biopharm; 2019 Sep; 142():165-178. PubMed ID: 31226366
[TBL] [Abstract][Full Text] [Related]
3. Stability behaviour of antiretroviral drugs and their combinations. 5: Characterization of novel degradation products of abacavir sulfate by mass and nuclear magnetic resonance spectrometry.
Kurmi M; Sahu A; Singh S
J Pharm Biomed Anal; 2017 Feb; 134():372-384. PubMed ID: 27889293
[TBL] [Abstract][Full Text] [Related]
4. Stability behaviour of antiretroviral drugs and their combinations. 2: Characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR spectrometry.
Kurmi M; Kushwah BS; Sahu A; Narayanam M; Singh S
J Pharm Biomed Anal; 2016 Jun; 125():245-59. PubMed ID: 27042808
[TBL] [Abstract][Full Text] [Related]
5. Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients.
Kurmi M; Sahu A; Ladumor MK; Kumar Bansal A; Singh S
J Pharm Biomed Anal; 2019 Mar; 166():174-182. PubMed ID: 30654205
[TBL] [Abstract][Full Text] [Related]
6. Stability behaviour of antiretroviral drugs and their combinations. 3: Characterization of interaction products of emtricitabine and tenofovir disoproxil fumarate by mass spectrometry.
Kurmi M; Singh DK; Tiwari S; Sharma P; Singh S
J Pharm Biomed Anal; 2016 Sep; 128():438-446. PubMed ID: 27344633
[TBL] [Abstract][Full Text] [Related]
7. Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 activity, and physiochemical and ADMET properties.
Kurmi M; Sahu A; Balhara A; Singh IP; Kulkarni S; Singh NK; Garg P; Singh S
J Pharm Biomed Anal; 2020 Jan; 178():112911. PubMed ID: 31627078
[TBL] [Abstract][Full Text] [Related]
8. Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.
Baira SM; R S; Talluri MVNK
J Pharm Biomed Anal; 2019 Feb; 165():399-409. PubMed ID: 30590338
[TBL] [Abstract][Full Text] [Related]
9. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
Singh DK; Sahu A; Handa T; Narayanam M; Singh S
J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
[TBL] [Abstract][Full Text] [Related]
10. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
Kathar N; Rajput N; Jadav T; Sengupta P
J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
[TBL] [Abstract][Full Text] [Related]
11. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
Narayanam M; Sahu A; Singh S
J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
[TBL] [Abstract][Full Text] [Related]
12. Characterization of degradation products of celiprolol hydrochloride using hyphenated mass and NMR techniques.
Sahu A; Balhara A; Raju N; Kumar BK; Sharma P; Singh DK; Singh S
J Pharm Biomed Anal; 2021 Apr; 197():113953. PubMed ID: 33618130
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
Adhikari S; Rustum AM
J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
[TBL] [Abstract][Full Text] [Related]
14. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
15. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
[TBL] [Abstract][Full Text] [Related]
16. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
17. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
18. Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate.
Golla VM; Kurmi M; Shaik K; Singh S
J Pharm Biomed Anal; 2016 Nov; 131():146-155. PubMed ID: 27589032
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
[TBL] [Abstract][Full Text] [Related]
20. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
